Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2015

Mar 11, 2015

30597_dirs_2015-03-11_527e5a35-116d-4282-bbd6-7dcf3b82ea14.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2015-03-09

Reporting Person: Conroy Kevin T (Director, President and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-03-09 Stock Option (right to buy) $23.38 A 71000 Acquired 2025-03-09 Common Stock (71000) Direct
2015-03-09 Restricted Stock Units $ A 97600 Acquired Common Stock (97600) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 243866 Direct
Common Stock 18454 Indirect
Common Stock 65189 Indirect

Footnotes

F1: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.